Clinical Trial Register Vital, All Stakeholders Must Act – Cochrane Directors
This article was originally published in The Tan Sheet
Executive Summary
The development of a comprehensive register of initiated clinical trials should be coordinated among all stakeholders to reduce the various harms associated with non-dissemination of trial information, a special communication in the July 23/30 Journal of the American Medical Association asserts
You may also be interested in...
Supplement GMP Warning Letters Make Modest Debut In 2010
Finalization of a settlement between the Federal Trade Commission and Rexall Sundown regarding unsupported cellulite treatment claims for the firm's Cellasene dietary supplement hinges upon approval of two related class action settlements pending in California and Florida, according to FTC
In Brief
Combe sells most of its OTC brands
People In Brief
Perrigo promotes in pricing, planning